Epsilon-COP Activators encompass a series of chemical compounds that indirectly bolster Epsilon-COP's pivotal role in vesicular transport. Forskolin, by directly increasing intracellular cAMP levels, potentially enhances the assembly and function of the coatomer protein complex, essential for retrograde transport from the Golgi to the endoplasmic reticulum. Similarly, 8-Br-cAMP, as a cAMP analog, and IBMX, through inhibition of phosphodiesterases, act to amplify PKA activity, leading to phosphorylation events that may promote Epsilon-COP's involvement in vesicle formation and trafficking. Adrenergic stimulation by Isoproterenol also raises cAMP levels, which could further facilitate Epsilon-COP's role in the coatomer assembly process. Selective phosphodiesterase inhibitors such as Rolipram, Cilostamide, Vinpocetine, Milrinone, Anagrelide, and Zardaverine specifically target different isoforms of the enzyme, thereby raising cAMP levels and indirectly promoting Epsilon-COP's function in the coatomer complex formation and maintenance of Golgi structure.
In addition to phosphodiesterase Activators, Pirlindole indirectly influences the cAMP signaling cascade by inhibiting monoamine oxidase A, potentially resulting in an enhanced function of Epsilon-COP in vesicle trafficking. Sildenafil, known for its PDE5 inhibitory action,represents a unique case where the increase in cGMP levels could also lead to a cross-talk with cAMP-dependent pathways, thus potentially supporting Epsilon-COP's role in vesicular transport. Collectively, these chemical activators do not act by upregulating the expression of Epsilon-COP but by enhancing the biochemical pathways that are crucial for its activation and function. The careful orchestration of cAMP and cGMP levels, as well as the selective inhibition of phosphodiesterases, creates an environment that favors the activation of PKA and subsequent phosphorylation events. These events are critical for the proper functioning of Epsilon-COP, which is intimately involved in the regulation of intracellular vesicle formation and movement, a process fundamental to the maintenance of cellular homeostasis and protein trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly raises cAMP levels, which may enhance Epsilon-COP activity by promoting vesicular transport and coatomer assembly involved in the trafficking from the Golgi complex to the endoplasmic reticulum. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP acts as a cAMP analog and activates PKA, leading to phosphorylation events that could enhance Epsilon-COP's role in vesicular budding and transport. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific phosphodiesterase inhibitor, increasing intracellular cAMP and activating PKA, thereby potentially enhancing the vesicle formation that Epsilon-COP facilitates. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can elevate cAMP levels, possibly enhancing Epsilon-COP function in vesicle trafficking by PKA activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective PDE4 inhibitor that raises intracellular cAMP levels, possibly promoting Epsilon-COP activity in coatomer protein complex assembly. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide inhibits PDE3, increasing cAMP levels, potentially facilitating the role of Epsilon-COP in vesicular coat formation. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine is a PDE1 inhibitor, which could lead to increased cAMP and indirectly enhance Epsilon-COP's role in vesicle formation through PKA activation. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone is a selective PDE3 inhibitor, which could raise cAMP levels and indirectly facilitate Epsilon-COP's function in maintaining the Golgi structure. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide inhibits PDE3, potentially increasing cAMP and indirectly enhancing Epsilon-COP's activity in retrograde Golgi-to-ER transport. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a dual PDE3 and PDE4 inhibitor that can elevate cAMP, potentially enhancing Epsilon-COP's activity in coatomer complex assembly. | ||||||